Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01034 (
cystatin C
)
3,397
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of total parenteral nutrition (TPN) in partially nephrectomized rats (n = 17) and sham-operated controls (n = 12) were evaluated and compared to the effect of low and high nitrogen oral diets (6% and 24% protein). TPN included fat (9 g/kg per day), high energy (1385 KJ/kg per day), and low nitrogen content (0.6 g N/kg per day, corresponding to 8% protein) either as essential amino acids (EAA) or as a mixture of essential and nonessential amino acids (
CAA
). The parenteral nutrition was administered intravenously via a permanent catheter continuously for 10 days. Most animals tolerated the treatment with no signs of overhydration or electrolyte imbalances. Uremic rats on TPN gained in weight similarly to control animals, whereas uremic rats given oral diets showed a lower weight increase. Both amino acid solutions promoted positive nitrogen balance and growth. Plasma urea dropped during TPN and low protein oral feeding in uremic and control rats, but not in the high protein-fed animals. Serum creatinine decreased with TPN but not with oral feeding in uremic rats. Albumin and hemoglobin levels were significantly reduced in all uremic rats irrespective of dietary treatment. The experimental model presented here could be useful for further studies on parenteral nutrition in
uremia
.
...
PMID:Effects of total parenteral nutrition in rats with experimental chronic renal failure. 680 93
Soluble brain proteins were analyzed regionally in a case of dialysis encephalopathy and compared to the findings in patients dying from uncomplicated
uremia
and acute myocardial infarction. Sixteen individual proteins were quantitated and the results may indicate that dialysis encephalopathy is accompanied by defects in the blood-brain barrier. However, such a postulated does not explain why certain proteins (
gamma-trace
protein) occur at very low concentrations in dialysis encephalopathy.
...
PMID:Soluble brain proteins in dialysis encephalopathy. 741 18
We determined the relationship between the levels of serum
cystatin C
or creatinine (s-Cr) and the grade of creatinine clearance (CCr) in patients with various glomerular diseases. Serum samples from 96 patients with glomerular diseases were obtained from our hospital. The levels of serum
cystatin C
were measured using the Dade Behring Cystatin C assay with the automated Dade Behring Nephelometer II (BNII). CCr levels were classified into six groups according to the Guidelines of the Japanese Society of Nephrology as follows: grade 1 (normal renal function); grade 2 (slight decrease of renal function); grade 3 (moderate decrease of renal function); grade 4 (severe decrease of renal function); grade 5 (renal failure), and grade 6 (
uremia
). The mean levels of serum
cystatin C
in grade 3 patients were significantly higher than those in grade 1. The mean levels of serum
cystatin C
in grades 4, 5 and 6 patients were also significantly higher than those in grade 1. However, the mean levels of serum Cr in grade 3 patients were not significantly higher than those in grade 1. The levels of s-Cr in grades 4, 5 or 6 patients were significantly higher than those in grade 1. In this study, an increase of serum
cystatin C
levels occurred earlier than that of s-Cr in various glomerular diseases. It appears that the levels of serum
cystatin C
may provide early prognostic marker of patients with various glomerular diseases rather than the levels of s-Cr.
...
PMID:Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. 1218 9